Showing results (1211-1220 of 1,229) with videos related to
Sort By:
Pageof 123
Nature Communications|November 23, 2023
ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancerShuang Shang, Chen Yang, Fei Chen, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 7, 2025
Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related servicesWang-Da Liu, Chien-Yu Cheng, Hsin-Yun Sun, et al.Scientific Reports|June 24, 2020
Traditional versus blended CPR training program: A randomized controlled non-inferiority studyCheng-Yu Chien, Shao-Yu Fang, Li-Heng Tsai, et al.Chinese Medical Journal|October 21, 2015
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical TrialYing Mao, Yu Yao, Li-Wei Zhang, et al.Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.Journal of Plant Physiology|February 5, 2025
A Gln alteration influences leaf morphogenesis by mediating gibberellin levels in tobaccoQi-Li Mi, Hong-Tao Lv, Fei-Fei Huang, et al.Trials|November 20, 2015
Effect of ATorvastatin On Chronic subdural Hematoma (ATOCH): a study protocol for a randomized controlled trialRongcai Jiang, Dong Wang, Wai Sang Poon, et al.Cancer Science|December 25, 2018
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemnessFrank H C Cheng, Hon-Yi Lin, Tzy-Wei Hwang, et al.Psychoradiology|April 26, 2024
A brain structural connectivity biomarker for autism spectrum disorder diagnosis in early childhoodXi Jiang, Xiao-Jing Shou, Zhongbo Zhao, et al.Human Vaccines & Immunotherapeutics|October 26, 2023
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialGuang-Wei Feng, Zhong-Fang Wang, Peng He, et al.Pageof 123